Ying J, Xu X, Zhou R, Chung AC, Ng SK, Fan X, Subramaniam M, Wong SH (2025) The gut microbiota in young adults with high-functioning autism spectrum disorder and its performance as diagnostic biomarkers
Eng et al., J Biol Chem, 1992 Parkes et al., Diabetes Care, 2013 #GLP1 #DrugDiscovery #FromBenchToBedside #NephMadness #MedicalEducation #Endocrinology #Nephrology GLP-1 Receptor Agonists from Gila Monster Venom GLP-1: from lizard venom to modern medicine One of the most fascinating origin stories in pharmacology
There, the disease was called Spring fever or Spring disease and was described as an often-fatal condition associated with skin lesions, bleeding gums, and lethargy
Clinical pharmaceutical trials in MASLD/MASH were identified on 31 December 2025 using PubMed and ClinicalTrials.gov using the following search terms: metabolic dysfunction-associated steatotic liver disease OR MASLD OR metabolic dysfunction-associated steatohepatitis OR MASH OR non-alcoholic fatty liver disease OR NAFLD OR non-alcoholic steatohepatitis OR NASH AND liver histology OR liver biopsy
This cumulative effect builds as your body's tissues and systems respond to the regenerative support